Ferra Joseph J Jr 4
4 · Elevation Oncology, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Ferra Joseph J Jr
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-02-15+25,000→ 134,482 total - Tax Payment
Common Stock
2025-02-15$0.67/sh−9,211$6,187→ 125,271 total - Award
Stock Option (Right to Buy)
2025-02-15+800,000→ 800,000 totalExercise: $0.67Exp: 2035-02-14→ Common Stock (800,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-15−25,000→ 75,000 total→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The stock option vests as to 25% of the total shares on February 15, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F4]The RSUs do not expire; they either vest or are canceled prior to the vesting date.